CREO AUGUST NEWS

From Prototype to Production, Operationalizing AlphaFold

AlphaFold, the AI-driven protein prediction tool that won the 2024 Nobel Prize in Chemistry, has the potential to transform research — but many organizations struggle with feasibility, cost, and deployment.

A leading U.S. biotech partnered with CREO to overcome those challenges. After a successful proof of concept, we delivered a tailored AlphaFold deployment within the client’s AWS environment. The result? Protein structure visualization in hours instead of weeks — at just 10% of the typical implementation cost.

By automating workflows, optimizing infrastructure, and enabling real-time 3D visualizations, we helped accelerate research while dramatically reducing costs. Scientists were able to focus on discovery, not delays.

This is just one of many ways our AI Services team is helping clients unlock value and make a broader impact in the world. We’re excited to keep sharing these stories with you as we shape the future of AI together.

Download Our Newest AI White Paper

AI must become a core component of every corporate strategy within the life sciences industry. This guide highlights the common challenges organizations face and the seven key reasons AI should be embedded in strategic planning.